MB
Michael Benkowitz
President and COO

Michael Benkowitz insider trades: UNITED THERAPEUTICS (UTHR) stock sales

President and COO, UNITED THERAPEUTICS Last trade Feb 23, 2026 94 Form 4 filings
$145.9M
Sold, last 12 months
15 sales
$0
Bought, last 12 months
0 buys
47
Open-market trades
since 2022
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

47 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 23, 2026UTHR↓ Sell$6.8M
Feb 17, 2026UTHR↓ Sell$10.8M
Feb 9, 2026UTHR↓ Sell$10.7M
Feb 2, 2026UTHR↓ Sell$10.6M
Jan 26, 2026UTHR↓ Sell$14.3M
Jan 20, 2026UTHR↓ Sell$6.8M
Jan 12, 2026UTHR↓ Sell$10.8M
Jan 5, 2026UTHR↓ Sell$7.1M
Jan 5, 2026UTHR↓ Sell$3.8M
Dec 15, 2025UTHR↓ Sell$11.2M
Dec 8, 2025UTHR↓ Sell$10.8M
Dec 1, 2025UTHR↓ Sell$10.8M
Nov 24, 2025UTHR↓ Sell$10.7M
Nov 17, 2025UTHR↓ Sell$10.6M
Nov 10, 2025UTHR↓ Sell$10.2M
Nov 3, 2025UTHR↓ Sell$9.7M
Oct 27, 2025UTHR↓ Sell$9.4M
Oct 20, 2025UTHR↓ Sell$9.6M
Oct 13, 2025UTHR↓ Sell$9.9M
Oct 6, 2025UTHR↓ Sell$10.1M
Sep 29, 2025UTHR↓ Sell$9.5M
Sep 22, 2025UTHR↓ Sell$9.4M
Sep 15, 2025UTHR↓ Sell$9.0M
Sep 9, 2025UTHR↓ Sell$6.5M
Sep 2, 2025UTHR↓ Sell$9.4M
Mar 10, 2025UTHR↓ Sell$640K
Mar 3, 2025UTHR↓ Sell$3.0M
Feb 24, 2025UTHR↓ Sell$3.6M
Feb 18, 2025UTHR↓ Sell$3.7M
Feb 10, 2025UTHR↓ Sell$3.5M
Feb 3, 2025UTHR↓ Sell$3.5M
Jan 27, 2025UTHR↓ Sell$3.7M
Jan 21, 2025UTHR↓ Sell$3.6M
Jan 13, 2025UTHR↓ Sell$3.6M
Jan 6, 2025UTHR↓ Sell$3.6M
Dec 30, 2024UTHR↓ Sell$3.6M
Dec 23, 2024UTHR↓ Sell$3.6M
Dec 16, 2024UTHR↓ Sell$3.7M
Dec 9, 2024UTHR↓ Sell$3.7M
Dec 2, 2024UTHR↓ Sell$3.7M
Nov 25, 2024UTHR↓ Sell$3.7M
Nov 18, 2024UTHR↓ Sell$3.6M
Nov 11, 2024UTHR↓ Sell$6.1M
Nov 7, 2024UTHR↓ Sell$10.0M
Nov 1, 2024UTHR↓ Sell$5.5M
Aug 7, 2024UTHR↓ Sell$8.1M
Dec 29, 2022UTHR↓ Sell$1.4M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other UTHR insiders

Open-market trades in the last 12 months

About Michael Benkowitz's insider trades

Michael Benkowitz is President and COO at UNITED THERAPEUTICS (UTHR). Since Dec 29, 2022, Michael has reported no open-market purchases and 47 sales worth $327.5M on SEC Form 4. In the last 12 months: 15 sales ($145.9M).

Their filings also include option exercises (85 filings), shares returned to the company (37 filings), grants and awards (8 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every UTHR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.